GenMod

GenMods vs. Basic Born

Genetic Modification, commonly called GenMod, is a highly advanced biomedical procedure in which engineered DNA is infused into an embryo to enhance specific traits. These enhancements may include increased intelligence, improved physical performance, refined appearance, and near total immunity to many diseases. Because of the complexity and regulation surrounding the process, all GenMod clinics operate exclusively on Earth, and the procedure remains prohibitively expensive for most families.

The technology was pioneered by Cardinal Bio Science, which originally trademarked the term GenMod. As other companies replicated the process and public usage became universal, the trademark was overturned, allowing multiple corporations to offer their own enhancement packages. Parents select from a menu of genetic options, with each option priced according to rarity, complexity, and projected efficacy, creating a marketplace of tailored genetic profiles rather than a simple list of standard upgrades.

Despite their advantages, GenMods do not guarantee perfection. Studies show that individuals with intelligence based GenMods average ten percent higher cognitive performance than Basic born individuals, but the range varies widely and outcomes remain probabilistic rather than fixed. Physical enhancements carry roughly a ninety percent reliability rate, and disease resistance modifications approach near total effectiveness, yet even these outcomes can be influenced by environment, lifestyle, and unforeseen biological interactions.

Socially, GenMods have created a subtle but persistent divide. Some enhanced individuals look down on the Basic born, a term used for those who received no genetic modifications at birth. A person born to two GenMod parents but without enhancements themselves is still considered Basic born, reinforcing an identity rooted in procedure rather than lineage. Long term studies remain inconclusive on whether GenMod traits reliably pass to future generations without direct intervention, leaving open questions about inheritance, social status, and long term population change.

In the modern era, GenMods are both a symbol of opportunity and a reminder of inequality, a scientific achievement that reshaped humanity while quietly redefining what it means to be normal. Advocacy groups, medical boards, and corporate interests continue to debate ethical boundaries, economic access, and regulatory oversight, but for many families the decision remains intensely personal, balancing hopes for a child’s future against the costs, uncertainties, and social consequences of enhancement.